Zdrowie i gospodarka · 06/05/1999

FDA Announces Submission of Information Collection for Review Under Paperwork Reduction Act

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in order to establish guidelines for the designation, development, and application review of products in fast-track drug development programs.